Preclinical evaluation of recombinant human interleukin-4
- 1 December 1992
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 64-65, 299-310
- https://doi.org/10.1016/0378-4274(92)90202-u
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytesPublished by Wiley ,2001
- Histomorphologic Observations for Cynomolgus Monkeys after Subchronic Subcutaneous Injection of Recombinant Human Interleukin-4Toxicologic Pathology, 1991
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Interleukin-1 Mitogenic Activity for Fibroblasts and Smooth Muscle Cells Is Due to PDGF-AAScience, 1989
- Regulation of synthesis and secretion of major rat acute‐phase proteins by recombinant human interleukin‐6 (BSF‐2/1L‐6) in hepatocyte primary culturesEuropean Journal of Biochemistry, 1988
- Platelet-activating factor and cellular immune responsesImmunology Today, 1987
- Changes in energy expenditure and fat metabolism in rats infused with interleukin‐1European Journal of Clinical Investigation, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- The Eosinophilic Leukocyte: Structure and FunctionPublished by Elsevier ,1986
- A significant part of macrophage-derived growth factor consists of at least two forms of PDGFCell, 1985